<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38741940</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2472-1972</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of the Endocrine Society</Title><ISOAbbreviation>J Endocr Soc</ISOAbbreviation></Journal><ArticleTitle>Letter to the Editor From J. Finsterer: "Explaining Long COVID: A Pioneer Cross-Sectional Study Supporting the Endocrine Hypothesis".</ArticleTitle><Pagination><StartPage>bvae086</StartPage><MedlinePgn>bvae086</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">bvae086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1210/jendso/bvae086</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Finsterer</LastName><ForeName>Josef</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2839-7305</Identifier><AffiliationInfo><Affiliation>Neurology Dpt., Neurology &amp; Neurophysiology Center, 1180 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endocr Soc</MedlineTA><NlmUniqueID>101697997</NlmUniqueID><ISSNLinking>2472-1972</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Endocr Soc. 2024 Apr 26;8(7):bvae087. doi: 10.1210/jendso/bvae087</RefSource><PMID Version="1">38895641</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>14</Day><Hour>3</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38741940</ArticleId><ArticleId IdType="pmc">PMC11089478</ArticleId><ArticleId IdType="doi">10.1210/jendso/bvae086</ArticleId><ArticleId IdType="pii">bvae086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ach T, Ben Haj Slama N, Gorchane A, et al. . Explaining long COVID: a pioneer cross-sectional study supporting the endocrine hypothesis. J Endocr Soc. 2024;8(3):bvae003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10801829</ArticleId><ArticleId IdType="pubmed">38260089</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgar RA, Rasool A, Wani AI, Bashir MI. Central diabetes insipidus (Infundibuloneuro hypophysitis): a late complication of COVID-19 infection. J Endocrinol Invest. 2021;44(12):2855&#x2010;2856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8253675</ArticleId><ArticleId IdType="pubmed">34215999</ArticleId></ArticleIdList></Reference><Reference><Citation>McMaster MW, Dey S, Fishkin T, Wang A, Frishman WH, Aronow WS. The impact of long COVID-19 on the cardiovascular system. Cardiol Rev. 2024. doi: 10.1097/CRD.0000000000000654</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000654</ArticleId><ArticleId IdType="pubmed">38285646</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumantri S, Rengganis I. Immunological dysfunction and mast cell activation syndrome in long COVID. Asia Pac Allergy. 2023;13(1):50&#x2010;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10166245</ArticleId><ArticleId IdType="pubmed">37389095</ArticleId></ArticleIdList></Reference><Reference><Citation>Baroni M, Beltrami S, Schiuma G, et al. . In situ endothelial SARS-CoV-2 presence and PROS1 plasma levels alteration in SARS-CoV-2-associated coagulopathies. Life (Basel). 2024;14(2):237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10890393</ArticleId><ArticleId IdType="pubmed">38398746</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziolos NR, Ioannou P, Baliou S, Kofteridis DP. Long COVID-19 pathophysiology: what do we know so far? Microorganisms. 2023;11(10):2458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10609046</ArticleId><ArticleId IdType="pubmed">37894116</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>